Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Times360Malawi Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::304896649.png) Times XXX Malawi [@Times360Malawi](/creator/twitter/Times360Malawi) on x 161.8K followers
Created: 2025-06-21 20:07:37 UTC

#Times360Malawi 
The U.S. Food and Drug Administration has approved Gilead Sciences, lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.
Gilead said the drug will be sold under the brand name Yeztugo.

![](https://pbs.twimg.com/media/Gt_jYaXXMAAdh1f.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1936516377101164561/c:line.svg)

**Related Topics**
[approved](/topic/approved)
[malawi](/topic/malawi)

[Post Link](https://x.com/Times360Malawi/status/1936516377101164561)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Times360Malawi Avatar Times XXX Malawi @Times360Malawi on x 161.8K followers Created: 2025-06-21 20:07:37 UTC

#Times360Malawi The U.S. Food and Drug Administration has approved Gilead Sciences, lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be sold under the brand name Yeztugo.

XXXXXX engagements

Engagements Line Chart

Related Topics approved malawi

Post Link

post/tweet::1936516377101164561
/post/tweet::1936516377101164561